Markus Warmuth, President & CEO at Monte Rosa Therapeutics, Inc. (GLUE), sold 5,467 shares at $18.92 ($103K) on 2026-05-01, disclosed to the SEC on 2026-05-05.
Scheduled sale ($103k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GLUE | SELL | 2026-04-15 | $141K | — | Filing → |
| GLUE | SELL | 2026-03-04 | $98K | — | Filing → |
| GLUE | SELL | 2026-01-09 | $257K | — | Filing → |